plerixafor has been researched along with Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Ji, Y; Yao, J | 1 |
| Butschkau, A; Genz, B; Vollmar, B; Wagner, NM | 1 |
| Cheung, CW; Chung, SK; Luo, X; Pan, Z; Sun, L; Tai, WL; Xia, Z | 1 |
| Allen, RJ; Carr, J; Chang, CC; Gupta, SM; Levine, JP; Lin, CD; Saadeh, PB; Tanaka, R; Tepper, OM; Warren, SM | 1 |
| Aoyama, T; Fujiwara, H; Fujiwara, T; Goto, K; Kanamori, H; Kawaguchi, T; Kawamura, I; Maruyama, R; Minatoguchi, S; Shiraki, T; Takemura, G; Takeyama, T; Tsujimoto, A; Watanabe, T | 1 |
| Fricker, S; Jiao, C; Schatteman, GC | 1 |
6 other study(ies) available for plerixafor and Ischemia
| Article | Year |
|---|---|
Extracellular ubiquitin protects cardiomyocytes during ischemia/hypoxia by inhibiting mitochondrial apoptosis pathway through CXCR4.
Topics: Animals; Apoptosis; Autophagy; Benzylamines; Cell Survival; Cyclams; Down-Regulation; Extracellular Space; Heterocyclic Compounds; Hypoxia; Ischemia; Mitochondria; Myocardial Infarction; Myocytes, Cardiac; Rats; Receptors, CXCR4; Ubiquitin; Up-Regulation | 2020 |
Protein z exerts pro-angiogenic effects and upregulates CXCR4.
Topics: Adenoviridae; Animals; Benzylamines; Blood Proteins; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Genetic Vectors; Heterocyclic Compounds; Hindlimb; Human Umbilical Vein Endothelial Cells; Ischemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Up-Regulation | 2014 |
Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperalgesia; Injections, Spinal; Ischemia; Ligation; Lumbar Vertebrae; Male; Mice, Inbred C57BL; Microglia; Models, Biological; Motor Activity; Neuralgia; Nociception; Pyridines; Rats; Receptors, CXCR4; Sciatic Nerve | 2016 |
Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair.
Topics: Animals; Benzylamines; Bone Marrow Cells; Cell Count; Chemokine CXCL2; Chemotaxis; Cyclams; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heterocyclic Compounds; Ischemia; Mice; Mice, Inbred C57BL; Skin; Stem Cells; Surgical Flaps; Wound Healing; Wounds and Injuries | 2010 |
Repeated phlebotomy augments angiogenesis to improve blood flow in murine ischemic legs.
Topics: Androstadienes; Animals; Benzylamines; Capillaries; Cyclams; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Erythropoietin; Femoral Artery; Heterocyclic Compounds; Hindlimb; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Ligation; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phlebotomy; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Regional Blood Flow; Signal Transduction; Stem Cells; Time Factors; Vascular Endothelial Growth Factor A; Wortmannin | 2010 |
The chemokine (C-X-C motif) receptor 4 inhibitor AMD3100 accelerates blood flow restoration in diabetic mice.
Topics: Animals; Antigens, CD34; Benzylamines; Blood Flow Velocity; Cyclams; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Heterocyclic Compounds; Humans; Ischemia; Kinetics; Leukocyte Transfusion; Mice; Receptors, CXCR4 | 2006 |